Enhanced Mass Spectrometry Capabilities Transform Pharma Analysis

Transforming Pharmaceutical Analysis with New Technology
Improved Pharma is poised to revolutionize the field of pharmaceutical analysis with its latest installation of the SCIEX TripleTOF 6600, coupled with an advanced SCIEX Exigent UHPLC system equipped with UV detection. This impressive system represents a significant leap in technology, enabling researchers to conduct detailed and versatile analyses of both small molecules and large biologics, enhancing the reliability of results in pharmaceutical development.
Understanding High-Resolution Accurate Mass Spectrometry
At the heart of this advancement is the technique known as Liquid Chromatography coupled with High-Resolution Accurate Mass Spectrometry (LC-HRAMS). This method excels in separating and identifying various analytes based on parameters such as retention times, mass-to-charge ratios, and fragmentation patterns. The result is a highly versatile analysis platform ideal for confident identification and quantitation of complex drug substances.
Key Features of the SCIEX TripleTOF 6600
The SCIEX TripleTOF 6600 is renowned for its outstanding performance, incorporating features that enhance data resolution and selectivity. This system includes a sophisticated quadrupole mass filter and a collision cell that allows for tandem mass spectrometry (MS/MS). Such capabilities are invaluable when it comes to characterizing unknown compounds in complex samples, enabling researchers to gain insights into molecular structures.
Applications in Pharmaceutical Research
This state-of-the-art platform finds immense utility in various research areas, including the sequencing of proteins and peptides, as well as in the quantitative detection of impurities at trace levels (parts per million to parts per billion). These features position the SCIEX TripleTOF 6600 as a critical tool in pharmaceutical development and quality control, ensuring products meet rigorous safety standards.
About Improved Pharma
Improved Pharma is dedicated to advancing pharmaceutical methods, formulations, and processes. Founded by Stephen and Sarah Byrn in 2006, the company has established itself as a leader in consulting and research services. Their expertise extends to a variety of domains, including solid-state form studies, formulation design, analytical testing, and strategic consulting for intellectual property development. Each service is crafted to support clients through the complexities of pharmaceutical development.
Contact Information
For inquiries regarding this acquisition or for more information on Improved Pharma's services, please reach out to Pam Smith at Improved Pharma. They can be contacted at (765) 463-9951, or through their official website for details on their extensive offerings.
Frequently Asked Questions
What is LC-HRAMS?
LC-HRAMS stands for Liquid Chromatography coupled with High-Resolution Accurate Mass Spectrometry, a technique for analyzing pharmaceutical compounds.
What is the significance of the SCIEX TripleTOF 6600?
The SCIEX TripleTOF 6600 is a leading platform that combines high resolving power with advanced mass spectrometry techniques, enhancing accurate analysis in pharmaceuticals.
Who founded Improved Pharma?
Improved Pharma was founded by Stephen and Sarah Byrn in 2006, aiming to improve pharmaceutical methods and processes through research and consulting.
What services does Improved Pharma offer?
Improved Pharma offers a range of services including solid-state form studies, analytical testing, and consulting on intellectual property matters.
How can I contact Improved Pharma?
You can reach Improved Pharma via phone at (765) 463-9951 or visit their website for more details and inquiries.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.